JADPRO Live 2018 Activities
JADPRO Live 2017 Activities
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
Collaborative Management of Patients with Advanced Estrogen Receptor-Positive Breast Cancer
At what point does a patient become a candidate for treatment with CDK inhibitors?
Lee S. Schwartzberg, MD, FACP
West Cancer Center
What are the most common side effects of CDK inhibitors?
What do APs need to know about hematologic side effects and how to manage them?
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.